|
|
Article: Artes Medical Initiates Market Launch and Commercial Sale of Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler.
- Article from:
- Business Wire
- Article date:
- August 5, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"The Feel Good Filler" Delivers Comfort, Affordability, and Immediate Results
SAN DIEGO -- Artes Medical (NASDAQ:ARTE) today announced the immediate availability of Elevess[TM], a new, FDA-approved hyaluronic acid (HA) based dermal filler for the treatment of facial wrinkles, such as nasolabial folds. As the first FDA-approved HA filler formulated with an anesthetic for patient comfort, Elevess is a safe and effective alternative to more expensive fillers.
Elevess delivers immediate treatment results that are comparable to other fillers, while the anesthetic provides patients with an easier, more comfortable injection experience. In addition, as a more ...